In EUR m
|
Q3 2022
|
Q3 2021
|
9M 2022
|
9M 2021
|
|
|
|
|
|
Revenue
|
436.3
|
414.3
|
1,246.3
|
1,100.2
|
EBITDA (adjusted)
|
133.6
|
138.7
|
353.9
|
318.9
|
Exceptional items
|
-2.7
|
-2.5
|
5.4
|
-5.6
|
EBITDA
|
130.9
|
136.1
|
359.3
|
313.3
|
Amortization, depreciation and impairment losses
|
-73.3
|
-75.6
|
-219.6
|
-231.1
|
thereof attributable to purchase price allocations and impairment losses
|
-6.8
|
-14.6
|
-20.3
|
-37.5
|
EBIT
|
57.6
|
60.5
|
139.7
|
82.2
|
Net finance income/costs
|
-5.4
|
-7.4
|
-17.7
|
-21.5
|
EBT
|
52.2
|
53.1
|
122.0
|
60.7
|
Taxes
|
-13.0
|
-12.9
|
-29.1
|
-14.8
|
Consolidated profit or loss for the period
|
39.1
|
40.2
|
92.9
|
45.9
|
Adjusted consolidated profit or loss for the period
|
46.3
|
56.2
|
104.2
|
83.4
|
|
|
|
|
|
Free cash flow (before M&A transactions)
|
32.2
|
76.7
|
115.9
|
159.4
|
Net debt (Sep. 30 / Dec 31.)
|
|
|
739.7
|
612.3
|